Antibiotic resistance among common bacterial enteric pathogens isolated from stool

Navaneeth, B.V.; Suganthi, N

doi:10.1007/bf02752289

Cited by 3 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With the emergence of multidrug resistant S. Typhi in the late 1980s, typhoid disease was found to be resistant to treatment with most of the commonly used antibiotics such as chloramphenicol, ampicillin, TMP-SMX, streptomycin and tetracycline. A study in the mid-1990s in Bangalore showed resistance to ampicillin, chloramphenicol, co-trimoxazole and nalidixic acid to be as high as 95% with 90% sensitivity to norfloxacin and ciprofloxacin [26]. Multidrug resistant outbreaks have been reported in 1995 from Bangalore with 76% resistance to ampicillin, 64% to chloramphenicol, and 75% to tetracycline [27].…”

Section: Treatmentmentioning

confidence: 99%

Epidemiology of typhoid and paratyphoid fever in India

Kanungo

Sur

2008

J Infect Dev Ctries

View full text Add to dashboard Cite

Enteric fever (typhoid and paratyphoid fever) is a major human bacterial infection. Although the disease is not common in industrialised countries, it remains an important and persistent health problem in developing nations. Hospital-based studies and outbreak reports from India indicate that enteric fever is a major public health problem in this country, with Salmonella enterica serovar Typhi (S. Typhi) the most common aetiologic agent but with an apparently increasing number of cases due to S. Paratyphi A (SPA). Because risk factors such as poor sanitation, lack of a safe drinking water supply and low socio economic conditions in resource-poor countries are amplified by the evolution of multidrug resistant salmonellae with reduced susceptibility to fluoroquinolone, treatment failure cases have been reported in India, which is associated with increased mortality and morbidity. Vaccination, which requires strict planning and proper targeting of the vulnerable age groups, is considered to be an effective tool in controlling this disease in endemic areas, given there is development of a conjugate vaccine against both serovars (S. Typhi and S. Para A).

show abstract

Section: Treatmentmentioning

confidence: 99%

Epidemiology of typhoid and paratyphoid fever in India

Kanungo

Sur

2008

J Infect Dev Ctries

View full text Add to dashboard Cite

show abstract

Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009

Cao

Pan

et al. 2012

International Journal of Antimicrobial Agents

150

112

View full text Add to dashboard Cite

Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010

Gu¹,

Xing²,

Pan³

et al. 2013

J Biomed Res

View full text Add to dashboard Cite

Shigellosis causes diarrheal disease in humans in both developed and developing countries, and multi-drug resistance in Shigella is an emerging problem. Understanding changing resistance patterns is important in determining appropriate antibiotic treatments. This meta-analysis systematically evaluated aminoglycoside resistance in Shigella. A systematic review was constructed based on MEDLINE and EMBASE databases. Random-effect models or fixed-effect models were used based on P value considering the possibility of heterogeneity between studies for meta-analysis. Data manipulation and statistical analyses were performed using software STATA 11.0. By means of meta-analysis, we found a lower resistance to three kinds of aminoglycosides in the Europe-America areas during the 12 year study period than that of the Asia-Africa areas. Kanamycin resistance was observed to be the most common drug resistance among Shigella isolates with a prevalence of 6.88% (95%CI: 6.36%-7.43%). Comparison of data from Europe-America and Asia-Africa areas revealed that Shigella flexneri resistance was greater than the resistance calculated for Shigella sonnei. Importantly, Shigella sonnei has played a significant role in aminoglycoside-resistance in recent years. Similarly, data showed that resistance to these drugs in children was higher than the corresponding data of adults. In conclusion, aminoglycoside-resistant Shigella is not an unusual phenomenon worldwide. Distribution in Shigella resistance differs sharply based on geographic areas, periods of time and subtypes. The results from the present study highlight the need for continuous surveillance of resistance and control of antibiotic usage.

show abstract

Antibiotic resistance among common bacterial enteric pathogens isolated from stool

Cited by 3 publications

References 5 publications

Epidemiology of typhoid and paratyphoid fever in India

Epidemiology of typhoid and paratyphoid fever in India

Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009

Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010

Contact Info

Product

Resources

About